Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
CURX
CURANEX PHARMACEUTICALS INC COMMON STOCK
NASDAQ
$4.40
▼ DOWN 4.35% (-0.20)

KEY STATISTICS

Market Cap$6.23 M
52w High$22.40
52w Low$3.58
Dividend Yield—
Frequency—
P/E-15.71
Volume21.29K
Shares Out.1.42M

COMPANY

LEADERSHIP

Jun Liu
CHIEF EXECUTIVE
Jun Liu

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 26, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
6

SPLIT RECORD

DATETYPERATIO
2026-08-20Reverse1:20

PRICE

$4.40 ▼ DOWN 4.35% (−$0.20)
OVERLAYS
$4.50$4.65$4.809:52 AM10:53 AM11:54 AM12:56 PM1:57 PM2:58 PM3:59 PM4.40

About Curanex Pharmaceuticals Inc Common Stock

https://www.curanexpharma.com ↗

Curanex Pharmaceuticals Inc., founded in 1996 and based in Jericho, NY, develops botanical drugs like Phyto-N to treat inflammatory diseases such as ulcerative colitis, dermatitis, COVID-19, diabetes, fatty liver, gout, and acne.

INDUSTRY

Biotechnology

A PRODUCT CURANEX PHARMACEUTICALS INC COMMON STOCK IS KNOWN FOR

Phyto-N
Phyto-N

Curanex Pharmaceuticals' lead preclinical botanical extract drug candidate targets moderate to severe ulcerative colitis and inflammatory diseases with anti-inflammatory properties.

COMPETITORS

COMPETITOR
CUE COMPARE
PLRX COMPARE
TLSA COMPARE

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book3
Overall Score2

SECTORS PEERS

PEERPRICE
PALI$1.59COMPARE
BCTX$4.21COMPARE
DARE$0.78COMPARE
LGVN$2.49COMPARE
PULM$1.44COMPARE
CUPR$1.79COMPARE
CRIS$1.00COMPARE
ASBP$8.54COMPARE